Literature DB >> 14713355

The potential of chitosan in ocular drug delivery.

María José Alonso1, Alejandro Sánchez.   

Abstract

This paper presents an overview of the potential of chitosan-based systems for improving the retention and biodistribution of drugs applied topically onto the eye. Besides its low toxicity and good ocular tolerance, chitosan exhibits favourable biological behaviour, such as bioadhesion- and permeability-enhancing properties, and also interesting physico-chemical characteristics, which make it a unique material for the design of ocular drug delivery vehicles. The review summarizes the techniques for the production of chitosan gels, chitosan-coated colloidal systems and chitosan nanoparticles, and describes their mechanism of action upon contact with the ocular mucosa. The results reported until now have provided evidence of the potential of chitosan gels for enhancing and prolonging the retention of drugs on the eye surface. On the other hand, chitosan-based colloidal systems were found to work as transmucosal drug carriers, either facilitating the transport of drugs to the inner eye (chitosan-coated colloidal systems containing indometacin) or their accumulation into the corneal/conjunctival epithelia (chitosan nanoparticles containing ciclosporin). Finally, the tolerance, toxicity and biodegradation of the carriers under evaluation were reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713355     DOI: 10.1211/0022357022476

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  28 in total

1.  Radiosynthesis and assessment of ocular pharmacokinetics of (124)I-labeled chitosan in rabbits using small-animal PET.

Authors:  Claudia Kuntner; Thomas Wanek; Martin Hoffer; Daniel Dangl; Margit Hornof; Herbert Kvaternik; Oliver Langer
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

2.  Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.

Authors:  Indu Pal Kaur; Deepika Aggarwal; Harinder Singh; Shilpa Kakkar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

Review 3.  Polymeric vectors for ocular gene delivery.

Authors:  Viral Tamboli; Gyan P Mishra; Ashim K Mitrat
Journal:  Ther Deliv       Date:  2011-04

Review 4.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

Review 5.  Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery.

Authors:  Muhammad Waseem Akram; Humzah Jamshaid; Fiza Ur Rehman; Muhammad Zaeem; Jehan Zeb Khan; Ahmad Zeb
Journal:  AAPS PharmSciTech       Date:  2021-12-01       Impact factor: 3.246

Review 6.  Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.

Authors:  Wiebke Ulbrich; Alf Lamprecht
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

7.  Novel topical ophthalmic formulations for management of glaucoma.

Authors:  Mohammed M Ibrahim; Abd-Elgawad H Abd-Elgawad; Osama A Soliman; Monica M Jablonski
Journal:  Pharm Res       Date:  2013-06-15       Impact factor: 4.200

8.  Dense chitosan surgical membranes produced by a coincident compression-dehydration process.

Authors:  Thomas P Dooley; April L Ellis; Maria Belousova; Don Petersen; Arthur A DeCarlo
Journal:  J Biomater Sci Polym Ed       Date:  2012-08-13       Impact factor: 3.517

9.  Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma.

Authors:  Mohammed Mostafa Ibrahim; Abd-Elgawad Helmy Abd-Elgawad; Osama Abd-Elazeem Soliman; Monica M Jablonski
Journal:  Transl Vis Sci Technol       Date:  2015-06-30       Impact factor: 3.283

10.  Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration.

Authors:  Melamangalam S Jayaraman; Dhruba J Bharali; Thangirala Sudha; Shaker A Mousa
Journal:  Mol Vis       Date:  2012-09-03       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.